Lexaria Bioscience (LEXX) Net Margin Growth (5y) (2022 - 2026)

Lexaria Bioscience (LEXX) Net Margin Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Lexaria Bioscience 7.17 Mn 1.65 Mn 20,000.00

Historic Data

Download Data
DateValue
Feb 28, 2026 721,047.00
Aug 31, 2025 266,904.00
May 31, 2025 592,160.00
Feb 28, 2025 408,267.00
Nov 30, 2024 1.02 Mn
Aug 31, 2024 348,081.00
May 31, 2024 409,811.00
Feb 29, 2024 789,295.00
Nov 30, 2023 395,138.00
Aug 31, 2023 517,720.00
May 31, 2023 552,896.00
Feb 28, 2023 729,346.00
Nov 30, 2022 419,086.00